Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

4-ethoxy-2-(piperazin-1-yl)-7-(pyridin-4-yl)-5H-pyrimido[5,4-b]indol

EU orphan designation number: EU/3/07/487   
Active ingredient: 4-ethoxy-2-(piperazin-1-yl)-7-(pyridin-4-yl)-5H-pyrimido[5,4-b]indol
Indication: Treatment of chronic lymphocytic leukaemia
Sponsor: BlackSwan Pharma GmbH
Deutscher Platz 5e, 04103 Leipzig, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/11/2007 Orphan designation EMEA/OD/057/07 (2007)5573 of 14/11/2007
20/01/2009 Change of name and/or address of sponsor
15/09/2009 Transfer of orphan designation EMEA/OD/057/07/T/01 (2009)7040 of 14/09/2009